Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02246270 · ClinicalTrials.gov registry record · Early Phase 1
Recurrent Urinary Tract Infections and Heparin (RUTIH Trial)
A Early Phase 1 study, sponsored by University of Oklahoma.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 34
- Enrollment target
NCT02246270 is a Early Phase 1 study that has completed, run by University of Oklahoma. The registered enrollment target is 34 participants.
The verdict
NCT02246270, a Early Phase 1 study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
Urinary Tract Infections (UTIs) are the second most common infection in the body. UTIs account for five percent of all visits to primary care physicians. Many women who have had a UTI will develop recurring urinary tract infections. Recent studies suggest that some women who suffer from recurrent UTIs have urinary tracts that allow bacteria to adhere to it more readily than others. Women who suffered from bladder inflammation and recurrent UTIs were noted to have reduced UTIs and bladder inflammation with heparin bladder instillations. Heparin is a highly-sulfated glycosaminoglycan and stored within the secretory granules of mast cells and released only into the vasculature at sites of tissue injury. It has been proposed that, in addition to anticoagulation, the main purpose of heparin is defense at such sites against invading bacteria and other foreign materials. The central question the research is intended to answer is does Heparin bladder instillations decrease UTI rates in patients.
Interventions
- OTHER Placebo
- DRUG Intravesical Heparin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2017-11-28 |
| Est. Completion | 2026-03-14 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02246270
The ClinicalTrials.gov registry entry for NCT02246270 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02246270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02246270 about?
NCT02246270 is a clinical study titled "Recurrent Urinary Tract Infections and Heparin (RUTIH Trial)". Urinary Tract Infections (UTIs) are the second most common infection in the body. UTIs account for five percent of all visits to primary care physicians. Many women who have had a UTI will develop recurring urinary tract infections. Recent studies suggest that some women who suffer from recurrent UT...
What is the current status of trial NCT02246270?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 34 participants. The study started on 2017-11-28. Estimated completion is 2026-03-14.
What interventions are being tested in trial NCT02246270?
The interventions under investigation include: Placebo (OTHER), Intravesical Heparin (DRUG).
Who is sponsoring clinical trial NCT02246270?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.